• MJHLS Brand Logo

© 2026 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Practice

Humira Not Cost Effective for RA, ICER Report Concludes

April 11th 2017

By Jackie Syrop

Article

Sandoz Brief Addresses US Supreme Court in Case Against Amgen

April 7th 2017

By Jackie Syrop

Article

European Drug Agency's Move Out of London, Spurred By Brexit, Could Disrupt Pipeline

April 6th 2017

By Christina Mattina

Article

Nominee for FDA Commissioner Vows to Strike Balance Before Senate Panel

April 6th 2017

By Jackie Syrop

Article

Biologics Superior for Relief of IBD Symptoms and Maintenance of Intestinal Health

April 5th 2017

By Jackie Syrop

Article

NHS May Use More "Stick" Than "Carrot" to Ensure Prescribing of Cheaper Biosimilars

March 28th 2017

By Jackie Syrop

Article

Policy Briefing Calls for More Efficient Biosimilar Approval Process

March 27th 2017

By Jackie Syrop

Article

Amgen Gains EC Approval for Biosimilar to Adalimumab

March 24th 2017

By Surabhi Dangi-Garimella, PhD

Article

Payer Cost Savings From Filgrastim Biosimilars Could Reach $2 Million Annually

March 23rd 2017

By Christina Mattina

Article

New Lawsuit Concerning Insulin Price-Fixing Filed in Federal Court

March 22nd 2017

By Jackie Syrop

Article